Author:
Ferenczi Ádám,Cserni Gábor
Reference28 articles.
1. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x
2. Ellis I, Allison KH, Dang C, et al. Invasive carcinoma of the breast histopathology reporting guide. Second edition. Sydney: International Collaboration on Cancer Reporting 2022. Available at: https://www.iccr-cancer.org/datasets/published-datasets/breast/invasive-carcinoma-of-the-breast/ (Last accessed: 15 November 2023)
3. Van Dooijeweert C, van Diest PJ, Ellis IO. Grading of invasive breast carcinoma: the way forward. Virchows Arch. 2022;480:33-43. https://doi.org/10.1007/s00428-021-03141-2
4. Cserni B, Bori R, Csörgő E, et al. ONEST (Observers Needed to Evaluate Subjective Tests) suggests four or more observers for a reliable assessment of the consistency of histological grading of invasive breast carcinoma: A reproducibility study with a retrospective view on previous studies. Pathol Res Pract. 2022;229:153718. https://doi.org/10.1016/j.prp.2021.153718
5. Sparano JA, Crager MR, Tang G, et al. Development and validation of a tool integrating the 21-gene recurrence score and clinical-pathological features to individualize prognosis and prediction of chemotherapy benefit in early breast cancer. J Clin Oncol. 2021;39:557-564. https://doi.org/10.1200/JCO.20.03007